ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 10 filers reported holding ACASTI PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $81,000 | +118.9% | 48,990 | 0.0% | 0.00% | +200.0% |
| Q2 2018 | $37,000 | -42.2% | 48,990 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $64,000 | -39.6% | 48,990 | -44.9% | 0.00% | -50.0% |
| Q4 2017 | $106,000 | -32.9% | 88,990 | -0.6% | 0.00% | -42.9% |
| Q3 2017 | $158,000 | +3.9% | 89,490 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $152,000 | 0.0% | 89,490 | 0.0% | 0.01% | +16.7% |
| Q1 2017 | $152,000 | -1.3% | 89,490 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $154,000 | -25.2% | 89,490 | 0.0% | 0.01% | -25.0% |
| Q3 2016 | $206,000 | +31.2% | 89,490 | 0.0% | 0.01% | +33.3% |
| Q2 2016 | $157,000 | -9.2% | 89,490 | 0.0% | 0.01% | -14.3% |
| Q1 2016 | $173,000 | -39.7% | 89,490 | 0.0% | 0.01% | -46.2% |
| Q4 2015 | $287,000 | – | 89,490 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 236,559 | $594,000 | 0.04% |
| INTACT INVESTMENT MANAGEMENT INC. | 89,490 | $287,000 | 0.01% |
| BANK OF MONTREAL /CAN/ | 210,484 | $537,000 | 0.00% |
| DEUTSCHE BANK AG\ | 215 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 200 | $1,000 | 0.00% |
| CITIGROUP INC | 30 | $0 | 0.00% |
| MORGAN STANLEY | 18 | $0 | 0.00% |
| Renaissance Technologies | 20,900 | $53,000 | 0.00% |
| ROYAL BANK OF CANADA | 588 | $1,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 400 | $1,000 | 0.00% |